| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dong Qin, Yan-Rong Jiang, Zijun Men. Gremlin in the Vitreous of Patients with Proliferative Diabetic Retinopathy and the Downregulation of Gremlin in Retinal Pigment Epithelial Cells. Journal of diabetes research. vol 2020. 2021-02-16. PMID:32377526. |
diabetic retinopathy (dr) is one of the most common causes of blindness globally. |
2021-02-16 |
2023-08-13 |
human |
| Benjamin G Spencer, Jose J Estevez, Ebony Liu, Jamie E Craig, John W Finni. Pericytes, inflammation, and diabetic retinopathy. Inflammopharmacology. vol 28. issue 3. 2021-02-09. PMID:31612299. |
diabetic retinopathy (dr) is a frequent complication of diabetes mellitus, and a common cause of vision impairment and blindness in these patients, yet many aspects of its pathogenesis remain unresolved. |
2021-02-09 |
2023-08-13 |
Not clear |
| Katherine J Wert, Vinit B Mahajan, Lijuan Zhang, Yuanqing Yan, Yao Li, Joaquin Tosi, Chun Wei Hsu, Takayuki Nagasaki, Kerstin M Janisch, Maria B Grant, MaryAnn Mahajan, Alexander G Bassuk, Stephen H Tsan. Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy. Signal transduction and targeted therapy. vol 1. 2021-02-03. PMID:27195131. |
diabetic retinopathy (dr) affects approximately one-third of diabetic patients and, if left untreated, progresses to proliferative dr (pdr) with associated vitreous hemorrhage, retinal detachment, iris neovascularization, glaucoma and irreversible blindness. |
2021-02-03 |
2023-08-13 |
mouse |
| Elio Striglia, Andrea Caccioppo, Niccolò Castellino, Michele Reibaldi, Massimo Port. Emerging drugs for the treatment of diabetic retinopathy. Expert opinion on emerging drugs. vol 25. issue 3. 2021-02-03. PMID:32715794. |
it is estimated that in 2020 about 4 million people worldwide suffered from blindness or visual impairment caused by dr. |
2021-02-03 |
2023-08-13 |
Not clear |
| Qin Jiang, Chang Liu, Chao-Peng Li, Shan-Shan Xu, Mu-Di Yao, Hui-Min Ge, Ya-Nan Sun, Xiu-Miao Li, Shu-Jie Zhang, Kun Shan, Bai-Hui Liu, Jin Yao, Chen Zhao, Biao Ya. Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction. The Journal of clinical investigation. vol 130. issue 7. 2021-02-02. PMID:32343678. |
diabetic retinopathy (dr) is the leading cause of blindness in working-age adults. |
2021-02-02 |
2023-08-13 |
human |
| Lifeng Gao, Mingming Huang, Xiaowen Luo, Tao Song, Xuxia Wang, Zhe Wang, Wei Zhang, Jiangyuan Chen, Hao Le. Microstructure abnormity in the optic nerve of type 1 diabetic rats revealed by diffusion tensor imaging study. Magnetic resonance imaging. vol 71. 2021-01-29. PMID:32434010. |
diabetic retinopathy (dr) is one of a major complication of type 1 diabetes mellitus (t1dm) and a leading cause of blindness. |
2021-01-29 |
2023-08-13 |
rat |
| Ali Sharif, Johan Jendle, Karl-Johan Hellgre. Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study. Diabetes therapy : research, treatment and education of diabetes and related disorders. vol 12. issue 1. 2021-01-29. PMID:33165837. |
screening for diabetic retinopathy (dr) prevents blindness through the early detection of sight-threatening retinal microvascular lesions that respond to timely local treatment. |
2021-01-29 |
2023-08-13 |
Not clear |
| Aiwen Miao, Jing Lu, Yishen Wang, Shudi Mao, Yamei Cui, Jianying Pan, Lisha Li, Yan Lu. Identification of the aberrantly methylated differentially expressed genes in proliferative diabetic retinopathy. Experimental eye research. vol 199. 2021-01-28. PMID:32721427. |
proliferative dr (pdr) is a more advanced stage of dr, which can cause severe impaired vision and even blindness. |
2021-01-28 |
2023-08-13 |
Not clear |
| Yolanda Valpuesta Martin, Gabriela Estefanía Pacheco Callirgos, Teresa Marcela Maroto Martín, Monserrat Piriz Veloso, Susana Hernández Santamaría, María Isabel López Gálve. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain. Rural and remote health. vol 20. issue 1. 2021-01-26. PMID:31941342. |
diabetic retinopathy (dr) is the leading cause of blindness in working-age adults in most developed countries. |
2021-01-26 |
2023-08-13 |
Not clear |
| Karkuzhali Suriyasekeran, Senthilkumar Santhanamahalingam, Manimegalai Duraisam. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review. Advances in experimental medicine and biology. vol 1307. 2021-01-19. PMID:32166636. |
the most widespread causes of blindness in the industrialized world are glaucoma, age related macular degeneration (armd), diabetic retinopathy (dr) and diabetic macula edema (dme). |
2021-01-19 |
2023-08-13 |
human |
| Yanni Zhou, Hui Li, Lisi Luo, Yue Chen, Qiang Chen, Wei Bian, Yanlin Yang, Ju Tan. Acupoint injection therapy for diabetic retinopathy: A protocol for systematic review and meta-analysis. Medicine. vol 100. issue 1. 2021-01-18. PMID:33429782. |
diabetic retinopathy (dr) is a common diabetic microvascular complication, and it is also the main cause of blindness in adults. |
2021-01-18 |
2023-08-13 |
Not clear |
| Abdullah Mohammed D Alharbi, Abdullah Masad S Alhazm. Prevalence, Risk Factors, and Patient Awareness of Diabetic Retinopathy in Saudi Arabia: A Review of the Literature. Cureus. vol 12. issue 12. 2021-01-14. PMID:33437546. |
diabetic retinopathy (dr) is the leading cause of blindness among working-age patients, and it has a prevalence of 34.6% among diabetics worldwide. |
2021-01-14 |
2023-08-13 |
Not clear |
| Zhiyan Su, Wei Liu, Jinkui Yan. Association between proliferative diabetic retinopathy and serum bile acid level in patients with type 2 diabetes mellitus. Endocrine, metabolic & immune disorders drug targets. 2021-01-13. PMID:33438572. |
diabetic retinopathy (dr) is one of the diabetic microvascular complications, which is also one of the important causes of blindness in adults. |
2021-01-13 |
2023-08-13 |
Not clear |
| Yi Dong, Cheng Qian, Guangming Wan, Panshi Yan, Shenzhi Liang, Jiong Wan. Schizandrin A Protects Human Retinal Pigment Epithelial Cell Line ARPE-19 against HG-Induced Cell Injury by Regulation of miR-145. Molecular therapy. Nucleic acids. vol 19. 2021-01-10. PMID:31794890. |
diabetic retinopathy (dr) is a serious complication of diabetes, which is the main cause of blindness among adults. |
2021-01-10 |
2023-08-13 |
human |
| Parag Shridhar Chandakkar, Ragav Venkatesan, Baoxin L. MIRank-KNN: multiple-instance retrieval of clinically relevant diabetic retinopathy images. Journal of medical imaging (Bellingham, Wash.). vol 4. issue 3. 2021-01-09. PMID:28894762. |
diabetic retinopathy (dr) is a consequence of diabetes and is the leading cause of blindness among 18- to 65-year-old adults. |
2021-01-09 |
2023-08-13 |
Not clear |
| Sanam Zeib Khan, Nida Ajmal, Rozeena Shaik. Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism. Canadian journal of diabetes. vol 44. issue 3. 2021-01-08. PMID:31859041. |
diabetic retinopathy (dr) is a microvascular complication of the retina of the eye and represents a major cause of blindness worldwide. |
2021-01-08 |
2023-08-13 |
Not clear |
| Shengchun Long, Jiali Chen, Ante Hu, Haipeng Liu, Zhiqing Chen, Dingchang Zhen. Microaneurysms detection in color fundus images using machine learning based on directional local contrast. Biomedical engineering online. vol 19. issue 1. 2021-01-08. PMID:32295576. |
as one of the major complications of diabetes, diabetic retinopathy (dr) is a leading cause of visual impairment and blindness due to delayed diagnosis and intervention. |
2021-01-08 |
2023-08-13 |
Not clear |
| Jingxia Du, Ying Wang, Yuanyuan Tu, Yang Guo, Xiaodong Sun, Xun Xu, Xiaojuan Liu, Li Wang, Xiao Qin, Manhui Zhu, E Son. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. Experimental eye research. vol 196. 2021-01-08. PMID:32407725. |
diabetic retinopathy (dr) is a neurovascular complication of diabetes mellitus that leads to blindness in the working-age population. |
2021-01-08 |
2023-08-13 |
mouse |
| Yi-Fen Chiang, Hsin-Yuan Chen, Yen-Jui Chang, Yin-Hwa Shih, Tzong-Ming Shieh, Kai-Lee Wang, Shih-Min Hsi. Protective Effects of Fucoxanthin on High Glucose- and 4-Hydroxynonenal (4-HNE)-Induced Injury in Human Retinal Pigment Epithelial Cells. Antioxidants (Basel, Switzerland). vol 9. issue 12. 2020-12-26. PMID:33255669. |
dr is the main cause of vision loss and blindness in diabetic patients. |
2020-12-26 |
2023-08-13 |
human |
| Ana Bastos de Carvalho, S Lee Ware, Feitong Lei, Heather M Bush, Robert Sprang, Eric B Higgin. Implementation and sustainment of a statewide telemedicine diabetic retinopathy screening network for federally designated safety-net clinics. PloS one. vol 15. issue 11. 2020-12-24. PMID:33147290. |
diabetic retinopathy (dr) is the leading cause of incident blindness among working-age adults in the united states. |
2020-12-24 |
2023-08-13 |
Not clear |